IQ GENETIC TECHNOLOGY LIMITED | +852 6746 9492 | info@juvguard.com
J
JuvGuard 久卫加

News & Research

Clinical observations, plain-language explainers and team updates from JuvGuard and our research partners.

Newsroom

The Latest in Exosome Research

Everything we publish is traceable to our own work: clinical observations, mechanism explainers and the manufacturing standards behind the product.

First-in-Human Study: Inhaled Stem Cell Vesicles for Pulmonary Fibrosis

A randomized, double-blind, placebo-controlled study published by a Tsinghua University team reported the safety and early findings of nebulized stem cell-derived extracellular vesicles.

Read the Full Story

Nebulized Exosomes in the Management of Lung Nodules

In a series of followed-up cases, some patients saw measurable changes in nodule size after nebulized therapy. Scheduled imaging remains the standard of care.

Read the Full Story

How Do Exosomes Rebuild Lung Tissue?

Starting with a vesicle just 30–150 nm across, we unpack how exosomes carry the signals that calm inflammation and orchestrate repair.

Read the Full Story

After the Virus: When Lung Recovery Stalls

Breathlessness that lingers months after a viral infection usually traces back to unresolved inflammation and early fibrosis. Here is what drives it, and how it can be supported.

Read the Full Story

What PIC/S GMP Really Means for an Inhaled Biologic

Inhaled delivery demands far more than oral products do. We break down every batch release test our product has to clear.

Read the Full Story

IQ GENETIC and HKRM Expand Access Across Asia-Pacific

Headquartered in Central, Hong Kong, the jointly developed product is now open to channel distribution, institutional partnerships and regional agencies across Asia-Pacific.

Read the Full Story

Why the Inhaled Route Matters

In pulmonary fibrosis, lung tissue gradually stiffens and thickens, and the surface available for gas exchange shrinks away. Intravenous delivery has to survive systemic dilution before it ever reaches the lung, so only a small fraction arrives at the alveoli.

Nebulization works differently. Stem cell-derived extracellular vesicles measure roughly 30–150 nm, small enough to ride an aerosol all the way to the alveolar surface and build a local concentration where it is needed, while limiting exposure elsewhere in the body.

How the Study Was Designed

The study was carried out and published independently by a Tsinghua University research team. It used a randomized, double-blind, placebo-controlled design with 24 participants. Forced vital capacity (FVC) was the primary endpoint; six-minute walk distance (6MWD) and safety monitoring were secondary. The findings were published in a Nature-family journal. We cite the published record only and have no affiliation or collaboration with the researchers or their institution.

What the Numbers Showed

Against placebo, the treated group gained an average of 12.5% in FVC and 45 metres in six-minute walk distance, with a clinical response rate of 83.3%. No serious adverse events were recorded throughout the study.

Reading the Results Responsibly

This is a Phase II study with a modest sample size. Individual responses vary, and the results cannot be generalized to everyone. JuvGuard is a wellness support product: it is not a substitute for pharmaceutical treatment or for the regimen your doctor has prescribed. Speak to your physician, or to one of our sales consultants, before deciding whether it suits you.

Back to the newsroom

After a Nodule Shows Up on a Scan

As low-dose CT becomes routine, more nodules are being found than ever. Most are benign or the residue of old inflammation, and the standard approach is periodic imaging to watch their size and shape over time.

The waiting is the hard part. For people who would rather not sit passively, we wanted to offer a gentle supportive option. It is not a drug, and it does not replace follow-up imaging or your doctor's judgement.

What Nebulized Exosomes May Do

Extracellular vesicles carry miRNA and proteins that modulate the local inflammatory environment and support the repair of damaged tissue. Delivered by nebulizer, those signalling molecules deposit directly onto the airway and alveolar surface.

What We Observed

Among cases followed at a partner clinic, one patient's 12 mm mixed ground-glass nodule in the right upper lobe was no longer visible on CT at week 24, and several others showed partial reduction. To be clear: not everyone responds the same way, and a single case is not evidence of a general effect.

Practical Guidance

Keep every scheduled scan, and keep your pulmonologist informed. JuvGuard is a wellness support product and does not replace medication or your prescribed care plan. If a nodule grows or changes shape during follow-up, follow your doctor's advice immediately.

Back to the newsroom

What Exactly Is an Exosome?

An exosome is a nanoscale vesicle that cells release naturally — about 30–150 nm across. Think of it as a parcel one cell sends to another, packed with miRNA, proteins and lipids that tell the recipient what to do next.

JuvGuard uses stem cell-derived exosomes carrying more than 450 bioactive factors, including growth factors and regulatory miRNA. That cargo is the basis of its repair activity.

Repair in Four Stages

First comes targeted delivery: surface recognition molecules let the vesicles accumulate around injured alveolar and fibroblast cells. Then immune rebalancing — dialling down pro-inflammatory signals such as IL-6 and TNF-α while lifting anti-inflammatory ones such as IL-10.

Third is regeneration: growth factors encourage alveolar cells to proliferate and rebuild damaged structure. Fourth is anti-fibrosis — suppressing the TGF-β/Smad pathway to reduce collagen deposition and slow the fibrotic process.

Why We Made It Inhalable

Inhalation needs no injection and can be done in a clinic or at home, while letting the vesicles coat the airway and alveolar surface directly. This delivery approach is patented by the Japan Patent Office and manufactured under PIC/S GMP conditions.

One caveat: this description of the mechanism draws on published literature and preclinical data, and individual responses differ. This article is educational only and does not constitute medical advice.

Back to the newsroom

Still Short of Breath, Months Later

Many people remain breathless and easily fatigued months after recovering from a viral infection, with ground-glass opacity — sometimes described as a white lung — still visible on imaging. Persistent symptoms like these usually reflect inflammation that never fully settled, rather than an ongoing infection.

How Inflammation Turns Into Fibrosis

Persistent inflammatory signalling activates fibroblasts, which secrete collagen in quantity. As collagen accumulates, lung tissue stiffens, elasticity falls and gas exchange becomes less efficient. That is the core of fibrosis, and it is also part of the pathway behind the year-on-year decline seen in COPD.

What Supportive Care Can Add

Pulmonary rehabilitation, not smoking and a regular routine remain the foundation. On top of that, nebulized stem cell exosomes can serve as a supportive option: their anti-inflammatory and repair signals act directly on the airway and alveoli, aiming to bring the lung micro-environment back into better balance.

How We Measure Progress

During follow-up we track changes in forced vital capacity, six-minute walk distance and quality-of-life scores. In our existing Phase II study, the treated group gained an average of 12.5% in FVC and 45 metres in 6MWD, with no serious adverse events observed.

Keeping It in Perspective

The study sample was small and responses vary, so these figures do not predict what any individual will experience. JuvGuard is a wellness support product, not a substitute for pharmaceutical treatment, and this article is not medical advice. Seek medical care promptly if symptoms worsen.

Back to the newsroom

Why Inhaled Products Are Held to a Higher Bar

An oral drug passes through the gut and liver before it ever reaches the bloodstream. An inhaled product goes straight into the lower respiratory tract, which has no equivalent defence. That is why inhaled products are held to a far stricter standard on sterility, endotoxin and particulate control.

What PIC/S GMP Covers

PIC/S is the Pharmaceutical Inspection Co-operation Scheme, and its GMP standard is mutually recognised by regulators in many countries and regions. Working to it means facility environment, raw materials, production steps, batch records and deviation handling all have to be traceable and reviewable.

What Every Batch Has to Clear

Batch release testing covers identity and purity, bioactive factor content, the 30–150 nm particle size distribution, sterility and endotoxin, plus the aerodynamic droplet profile after nebulization. We also commission SGS to run independent third-party testing as a check outside our own quality system.

Technology and IP Protection

The nebulization technology behind this product is patented by the Japan Patent Office, and continues to evolve through our collaboration with research partners in Hong Kong and the mainland. Manufacturing is carried out in PIC/S GMP-compliant facilities so that every batch performs consistently.

Storage and Handling

Exosomes are temperature sensitive and must be stored and shipped under cold-chain conditions throughout. Our sales consultants will walk you through storage requirements, reconstitution and nebulizer handling at the point of delivery, so the product reaches you in the condition it was made.

Back to the newsroom

A Joint Product, Now Open to Partners

JuvGuard is brought to market jointly by IQ GENETIC TECHNOLOGY LIMITED and HKRM. Headquartered at The Center, 99 Queen's Road Central, Hong Kong, the partnership supplies nebulized stem cell exosome products to Asia-Pacific and beyond.

Three Routes to Work With Us

We are opening three routes — channel distribution, clinical institution partnership and regional agency — backed by six areas of support: brand assets, product training, marketing materials, a transparent pricing structure, territory protection and commission.

Training and Scientific Support

Every new partner receives training on product knowledge, mechanism of action and compliant messaging, along with clinical study material and a summary of the Nature-family publication for discussions with institutional clients.

We're Recruiting Sales Consultants

We're recruiting sales consultants, with flexible hours, professional training and a competitive commission structure. Interested in joining us? Message us on WhatsApp.

How to Reach Us

WhatsApp and phone: +852 6746 9492. Email: info@juvguard.com. Address: The Center, 99 Queen's Road Central, Central, Hong Kong. For partnership discussions or to apply as a consultant, message us directly on WhatsApp.

Back to the newsroom

Have a Question? Ask Us Directly

Research data, suitability or partnership terms — a sales consultant will take you through all of it.

This product is a wellness support product and is not a substitute for pharmaceutical treatment. The information provided is for reference only and does not constitute medical advice.

Talk to Sales